Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 1, 2021
[Elucidation for Intratumor Localization of a DDS-based Anticancer Drug and Enhancement of Its Therapeutic Effects via Improvement of the Tumor Microenvironment]Hidenori AndoAdvanced Drug Delivery Reviews|August 12, 2020
An RNAi therapeutic, DFP-10825, for intraperitoneal and intrapleural malignant cancersHidenori Ando, Tatsuhiro IshidaEuropean Journal of Pharmacology|April 30, 2023
A polyethylene glycol-conjugate of deoxycytidine analog, DFP-14927, produces potential antitumor effects on pancreatic tumor-xenograft murine models via inducing G2/M arrestHidenori Ando, Kiyoshi Eshima, Tatsuhiro IshidaCancer Reports (Hoboken, N.J.)|June 26, 2021
A novel polyethylene glycol (PEG)-drug conjugate of Venetoclax, a Bcl-2 inhibitor, for treatment of acute myeloid leukemia (AML)Hidenori Ando, Yuta Murakami, Kiyoshi Eshima, et al.International Journal of Pharmaceutics|January 9, 2025
An in vitro nanocarrier-based B cell antigen loading system; tumor growth suppression via transfusion of the antigen-loaded B cells in vivoYoshino Kawaguchi, Taro Shimizu, Haruka Takata, et al.Biological & Pharmaceutical Bulletin|July 5, 2022
Development of a Nanocarrier-Based Splenic B Cell-Targeting System for Loading Antigens in VitroYoshino Kawaguchi, Taro Shimizu, Hidenori Ando, et al.Biological & Pharmaceutical Bulletin|February 3, 2016
Hepatic Tumor Metastases Cause Enhanced PEGylated Liposome Uptake by Kupffer CellsMasami Ukawa, Yukako Fujiwara, Hidenori Ando, et al.Chemical & Pharmaceutical Bulletin|May 1, 2022
Development of an Antigen Delivery System for a B Cell-Targeted Vaccine as an Alternative to Dendritic Cell-Targeted VaccinesTaro Shimizu, Yoshino Kawaguchi, Hidenori Ando, et al.Vaccine|January 22, 2021
Lymphoid follicle antigen (Ag) delivery and enhanced rodent humoral immune responses mediated by Ag-containing PEGylated liposomesTaro Shimizu, Yuki Watanabe, Hidenori Ando, et al.Journal of Pharmaceutical Sciences|June 24, 2025
Protein-bound cisplatin could exhibit an efficient antitumor effect in vivoNana Cristina Amorim Matsuo, Hidenori Ando, Haruka Takata, et al.Pageof 9